Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 17.9% | 12.5% |
ROCE | 22.0% |
Latest | F'cast | |
---|---|---|
P/E | 10.5 | 16.5 |
PEG | n/a | n/a |
Pr/Revenue | 1.6 | 1.5 |
Pr/Book | 0.8 |
Latest | F'cast | |
---|---|---|
Revenue | 36.6% | 2.2% |
PBT | n/a | 10.4% |
EPS | n/a | -36.7% |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Apr-21 | 10.35 | (6.33) | (1.50)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-22 | 12.06 | (6.13) | (1.10)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-23 | 17.31 | (7.29) | (1.40)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-24 | 19.40 | (3.45) | (0.60)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-25 | 26.51 | 3.08 | 0.60p | 8.5 | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Apr-26 | 27.10 | 3.40 | 0.38p | 16.4 | n/a | -37% | n/a | 0.0% |
30-Apr-27 | 30.50 | 2.30 | 0.20p | 31.3 | n/a | -47% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Final Results | 16-Sep-2025 | 07:00 | RNS |
New Biosecurity Award from UK MoD | 11-Aug-2025 | 07:00 | RNS |
$5m received under Siemens Healthineers agreement | 28-Jul-2025 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 6.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 7.50 |
52 Week Low | 4.45 |
Volume | 1,033,874 |
Shares Issued | 654.99m |
Market Cap | £40.94m |
Beta | 0.01 |
RiskGrade | 527 |
Value | ![]() |
---|
Price Trend | ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:59 | 47,974 @ 6.25p |
15:19 | 10,000 @ 6.25p |
15:14 | 19,414 @ 6.21p |
15:06 | 15,921 @ 6.25p |
15:03 | 7,391 @ 6.24p |
CEO | Arnab Basu |
CFO | Claire Burgess |
You are here: research